FindTrial
Sign In

Endoscopic mucosal resection of colorectal polyp in anticoagulated patients

Endoscopic mucosal resection of colorectal polyp in anticoagulated patients - EMR in anticoagulated patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000021416
Enrollment
90
Registered
2016-03-09
Start date
2016-03-09
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal polyp

Interventions

Colorectal EMR in anticoagulated patients (until 30 days after procedure)

Sponsors

Fukuyama City Hospital
Lead Sponsor
Okayama University Hospital, Okayama saiseikai General Hospital, Mitoyo General Hospital, Kagawa Prefectural Central Hospital, Okayama City Hospital, Tsuyama Chuo Hospital, Okayama Red Cross Hospital, Sumitomo Besshi Hospital, Himeji Red Cross Hospital, Hiroshima City Hospital, Fukuyama Medical Center,
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) patients with colorectal polyp becoming the indication of EMR: 2) Under single use of anticoagulant agent 3) PT-INR is less than 2.6 4) Written Informed consent.

Exclusion criteria

Exclusion criteria: 1) PT-INR is 2.6 or more 2) Under combination use of antiplatelet agents. 3) patients with severe organ failure (herat, liver,renal) 4) patients who have been judged as inappropriate for this study

Design outcomes

Primary

MeasureTime frame
perioperative and postoperative bleeding ( until 30 days after procedure)—

Secondary

MeasureTime frame
thromboembolism( until 30 days after procedure) variables as bleeding risk factor comparison between warfarin and DOAC—

Countries

Japan

Contacts

Public ContactSayo Kobayashi

Fukuyama City Hospital Department of Internal medicine

sayo44@hotmail.co.jp084-941-5151

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026